Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...
Among patients with resected gallbladder cancer, the addition of chemoradiation to chemotherapy treatment did not improve ...
Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...
News Medical on MSN1d
Chemotherapy linked to persistent nerve pain in 4 in 10 cancer patientsWorldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...
Subgroup analyses showed that patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ...
Opdivo plus chemo showed long-term survival advantages in Chinese patients with advanced gastric, gastroesophageal junction ...
Asian News International on MSN2d
Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer PatientsNew Delhi [India] / London [UK] / Munich [Germany], January 28: Datar Cancer Genetics (DCG) has launched a revolutionary ...
Health and Me on MSN6h
Chemotherapy Can Lead To Nerve Damage Called The Peripheral Neuropathy, Know What It MeansUnder this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...
The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in ...
Adding CRT to chemotherapy did not improve RFS in resected gallbladder cancer in the phase 3 ACCELERATE trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback